|
Promising Phase II Data For Tiotropium In Adolescent Asthma Patients
Science 2.0 [1] Boehringer Ingelheim announced that the company has a comprehensive confirmatory phase III trial programme named UniTinA-asthma(TM) ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma. |
View full post on asthma – Google News